Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines

被引:44
作者
Schweitzer, BL [1 ]
DeKoter, RP [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA
关键词
D O I
10.4049/jimmunol.172.1.144
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A number of presumptive target genes for the Ets-family transcription factor PU.1 have been identified in the B cell lineage. However, the precise function of PU.1 in B cells has not been studied because targeted null mutation of the PU.1 gene results in a block to lymphomyeloid development at an early developmental stage. In this study, we take advantage of recently developed PU.1(-/-)Spi-B-/- IL-7 and stromal cell-dependent progenitor B (pro-B) cell lines to analyze the function of PU.1 and Spi-B in B cell development. We show that contrary to previously published expectations, PU.1 and/or Spi-B are not required for IgH chain (IgH) gene transcription in pro-B cells. In fact, PU.1(-/-)Spi-B-/- pro-B cells have increased levels of IgH transcription compared with wild-type pro-B cells. In addition, high levels of Igkappa transcription are induced after IL-7 withdrawal of wild-type or PU.1(-/-)Spi-B-/- pro-B cells. In contrast, we found that Iglambda transcription is reduced in PU.1(-/-)Spi-B-/- pro-B cells relative to wild-type pro-B cells after IL-7 withdrawal. These results suggest that Iglambda, but not IgH or Igkappa, transcription, is dependent on PU.1 and/or Spi-B. The PU.1(-/-)Spi-B-/- pro-B cells have other phenotypic changes relative to wild-type pro-B cells including increased proliferation, increased CD25 expression, decreased c-Kit expression, and decreased RAG-I expression. Taken together, our observations suggest that reduction of PU.1 and/or Spi-B activity in pro-B cells promotes their differentiation to a stage intermediate between late pro-B cells and large pre-B cells.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 66 条
[41]  
Muller S, 1996, ONCOGENE, V13, P1955
[42]   Mechanism of E47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts [J].
Nagulapalli, S ;
Goheer, A ;
Pitt, L ;
McIntosh, LP ;
Atchison, ML .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) :7337-7350
[43]   REGULATION OF LYMPHOID-SPECIFIC IMMUNOGLOBULIN-MU HEAVY-CHAIN GENE ENHANCER BY ETS-DOMAIN PROTEINS [J].
NELSEN, B ;
TIAN, G ;
ERMAN, B ;
GREGOIRE, J ;
MAKI, R ;
GRAVES, B ;
SEN, R .
SCIENCE, 1993, 261 (5117) :82-86
[44]   Requirement for B cell linker protein (BLNK) in B cell development [J].
Pappu, R ;
Cheng, AM ;
Li, B ;
Gong, Q ;
Chiu, C ;
Griffin, N ;
White, M ;
Sleckman, BP ;
Chan, AC .
SCIENCE, 1999, 286 (5446) :1949-1954
[45]   Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow [J].
Pear, WS ;
Miller, JP ;
Xu, LW ;
Pui, JC ;
Soffer, B ;
Quackenbush, RC ;
Pendergast, AM ;
Bronson, R ;
Aster, JC ;
Scott, ML ;
Baltimore, D .
BLOOD, 1998, 92 (10) :3780-3792
[46]   A new mathematical model for relative quantification in real-time RT-PCR [J].
Pfaffl, MW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (09) :E45
[47]   PU-1 RECRUITS A 2ND NUCLEAR FACTOR TO A SITE IMPORTANT FOR IMMUNOGLOBULIN-KAPPA-3' ENHANCER ACTIVITY [J].
PONGUBALA, JMR ;
NAGULAPALLI, S ;
KLEMSZ, MJ ;
MCKERCHER, SR ;
MAKI, RA ;
ATCHISON, ML .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (01) :368-378
[48]   The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor [J].
Rao, S ;
Garrett-Sinha, LA ;
Yoon, J ;
Simon, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34245-34252
[49]   CHARACTERIZATION OF SPI-B, A TRANSCRIPTION FACTOR RELATED TO THE PUTATIVE ONCOPROTEIN SPI-1/PU.1 [J].
RAY, D ;
BOSSELUT, R ;
GHYSDAEL, J ;
MATTEI, MG ;
TAVITIAN, A ;
MOREAUGACHELIN, F .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (10) :4297-4304
[50]  
Ray RJ, 1998, J IMMUNOL, V160, P5886